MimiVax

About

Edit Template Pipeline SurVaxM Clinical Trials About Leadership Team News Contact Disrupting cancer through SurVaxM immunotherapy At MimiVax, our mission is to disrupt cancer. We are dedicated to improving survival and sending hope to cancer patients SurVaxM is a first-of-its-kind, peptide mimic immunotherapeutic vaccine (immunotherapy) that targets survivin, a cell-survival protein present in nearly all […]